{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:57Z","timestamp":1791182037670,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.leukres.2008.09.027","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T10:59:12Z","timestamp":1225882752000},"page":"735-741","source":"Crossref","is-referenced-by-count":61,"title":["Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KITD816V"],"prefix":"10.1016","volume":"33","author":[{"given":"Celalettin","family":"Ustun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Corless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Fiskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Manaloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Kepten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Jillella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.09.027_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.leukres.2008.09.027_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000048186","article-title":"Spectrum of associated clonal hematologic non-mast cell lineage disorders occurring in patients with systemic mastocytosis","volume":"127","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.leukres.2008.09.027_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jmgm.2004.04.003","article-title":"Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase","volume":"23","author":"Foster","year":"2004","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.leukres.2008.09.027_bib4","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-KIT in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2008.09.027_bib5","first-page":"1115","article-title":"Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-KIT whereas the kinase domain mutant D816VKit is resistant","volume":"1","author":"Frost","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2008.09.027_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3324\/haematol.11339","article-title":"Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT","volume":"92","author":"Gleixner","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.09.027_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","article-title":"Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.027_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.CAN-05-2050","article-title":"Dasatinib (BMS-354825), a dual SRC\/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies","volume":"66","author":"Schittenhelm","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2008.09.027_bib9","doi-asserted-by":"crossref","first-page":"1039a","DOI":"10.1182\/blood.V110.11.3551.3551","article-title":"Phase II Study of Dasatinib (SPRYCELTM) in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis [Abstract]","volume":"110","author":"Verstovsek","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.027_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ajh.10322","article-title":"Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-KIT mutations","volume":"73","author":"Pullarkat","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2008.09.027_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.leukres.2006.03.006","article-title":"Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone","volume":"31","author":"Pullarkat","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.09.027_bib12","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.exphem.2007.08.016","article-title":"The origin of neoplastic mast cells in systemic mastocytosis with AML1\/ETO-positive acute myeloid leukaemia","volume":"35","author":"Nagai","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2008.09.027_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830380319","article-title":"Concurrent acute myeloid leukemia and systemic mastocytosis","volume":"38","author":"Wong","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2008.09.027_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jcp.2003.012864","article-title":"Acute myeloid leukaemia with t(8;21) associated with \u201coccult\u201d mastocytosis. Report of an unusual case and review of the literature","volume":"57","author":"Bernd","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2008.09.027_bib15","doi-asserted-by":"crossref","first-page":"1042a","DOI":"10.1182\/blood.V110.11.3562.3562","article-title":"Response to dasatinib in patients with aggressive systemic mastocytosis with D816V Kit Mutation [Abstract]","volume":"110","author":"Rondoni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.027_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0609.2008.01048.x","article-title":"Dasatinib therapy for systemic mastocytosis: four cases","volume":"80","author":"Purtill","year":"2008","journal-title":"Eur J Haem"},{"key":"10.1016\/j.leukres.2008.09.027_bib17","doi-asserted-by":"crossref","first-page":"258b","DOI":"10.1182\/blood.V110.11.4656.4656","article-title":"Systemic mastocytosis with c-KITD816V mutation treated with dasatinib (abstract(","volume":"110","author":"Benz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.027_bib18","doi-asserted-by":"crossref","first-page":"460a","DOI":"10.1182\/blood.V110.11.1541.1541","article-title":"Delineation of a KIT-Independent oncogenic pathway in neoplastic mast cells that involves Lyn and Btk, and can be disrupted by the KIT\/Lyn\/Btk-Targeting drug (abstract(","volume":"110","author":"Gleixner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.09.027_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.iac.2006.05.003","article-title":"KIT mutations in mastocytosis and their potential as therapeutic targets","volume":"26","author":"Gotlib","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.leukres.2008.09.027_bib20","first-page":"185","article-title":"Regulation of normal and neoplastic human mast cell development in mastocytosis","volume":"116","author":"Metcalfe","year":"2005","journal-title":"Trans Am Clin Climatol Assoc"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T22:12:09Z","timestamp":1589062329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0145212608004529"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.09.027","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}